Christopher Brooke
Chief Operating Officer bij SwanBio Therapeutics, Inc.
Vermogen: 177 405 $ op 31-03-2024
Profiel
Christopher Brooke is the founder of Rumpus Therapeutics.
He is currently the Chief Operating Officer at SwanBio Therapeutics, Inc. where he started in 2023.
Prior to this, he was the Chief Operating Officer at Aytu Biopharma, Inc. from 2021 to 2023.
Mr. Brooke received his undergraduate degree from Colgate University and his MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AYTU BIOPHARMA, INC.
1.05% | 11-08-2023 | 58 357 ( 1.05% ) | 177 405 $ | 31-03-2024 |
Actieve functies van Christopher Brooke
| Bedrijven | Functie | Begin |
|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Chief Operating Officer | 16-10-2023 |
Eerdere bekende functies van Christopher Brooke
| Bedrijven | Functie | Einde |
|---|---|---|
| AYTU BIOPHARMA, INC. | Chief Operating Officer | 13-10-2023 |
| Rumpus Therapeutics | Founder | - |
Opleiding van Christopher Brooke
| Colgate University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Rumpus Therapeutics | |
| Aytu Biopharma, Inc. |
